Medication is prescribed at provider discretion and is one possible component of a larger protocol
One of the innovative treatments now available at our clinic is semaglutide GLP-1, a medication that has been shown to help adults who are overweight or have obesity lose weight safely and effectively
declares having received consulting honoraria from Amgen, Boehringer Ingelheim, Merck, Pfizer, Aegerion, Novartis, Sanofi, Takeda, Novo Nordisk and Bayer and research grants from the British Heart Foundation, the MRC, the National Institute for Health and Care Research, Public Health England, Merck Sharp & Dohme (MSD), Pfizer, Aegerion, Colgate and Roche
Eli Lilly has not submitted regulatory applications in any country as of early 2026
Insert the needle into the skin at a straight angle, as shown in the diagram in the patient information leaflet